作者
R Martin-Santos, J a Crippa, A Batalla, Sagnik Bhattacharyya, Z Atakan, S Borgwardt, Paul Allen, M Seal, K Langohr, M Farré, Antonio Waldo Zuardi, P K McGuire
发表日期
2012/11/1
来源
Current pharmaceutical design
卷号
18
期号
32
页码范围
4966-4979
出版商
Bentham Science Publishers
简介
Rationale: Animal and humans studies suggest that the two main constituents of cannabis sativa, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have quite different acute effects. However, to date the two compounds have largely been studied separately. Objective: To evaluate and compare the acute pharmacological effects of both THC and CBD in the same human volunteers. Methods: A randomised, double-blind, cross-over, placebo controlled trial was conducted in 16 healthy male subjects. Oral THC 10 mg or CBD 600 mg or placebo was administered in three consecutive sessions, at one-month interval. Physiological measures and symptom ratings were assessed before, and at 1, 2 and 3 hours post drug administration. The area under the curve (AUC) between baseline and 3 hours, and the maximum absolute change from baseline at 2 hours were analysed by one-way repeated measures …
引用总数
201220132014201520162017201820192020202120222023202413181272724324149303213
学术搜索中的文章